Recent advances in biomedical applications of accelerator mass spectrometry

Journal of Biomedical Science

Volumn 16, Issue 1, 2009, Pages

  Hah, Sang Soo ^a  

^a Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACCELETOR MASS SPECTROMETRY; ARTICLE; DRUG METABOLISM; MASS SPECTROMETRY; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; PRIORITY JOURNAL; TOXIN ANALYSIS; ANIMAL; CHEMISTRY; DNA DAMAGE; EQUIPMENT DESIGN; HUMAN; MAGNETIC AND ELECTROMAGNETIC EQUIPMENT; METHODOLOGY; OXIDATIVE STRESS; PHARMACOKINETICS; REVIEW;

8 OXO 7 HYDRODEOXYGUANOSINE; 8-OXO-7-HYDRODEOXYGUANOSINE; CARBON; DEOXYGUANOSINE; DRUG DERIVATIVE; RADIOISOTOPE;

ANIMALS; BIOMEDICAL RESEARCH; CARBON RADIOISOTOPES; DEOXYGUANOSINE; DNA DAMAGE; EQUIPMENT DESIGN; HUMANS; MASS SPECTROMETRY; OXIDATIVE STRESS; PARTICLE ACCELERATORS; PHARMACOKINETICS; RADIOISOTOPES;

EID: 68149139355     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-16-54     Document Type: Article

References (92)

1. Carbon-14: direct detection at natural concentrations. DE Nelson RG Korteling WR Stott, Science 1977 198 507 508 10.1126/science.198.4316.507 17842138
2. Radiocarbon dating using electrostatic accelerators: Negative-ions provide key. CL Bennett RP Beukens MR Colver HE Gove RB Liebert AE Litherland KH Purser WE Sondheim, Science 1977 198 508 510 10.1126/science.198.4316.508 17842139
3. Accelerator mass spectrometry: Isotope quantification at attomole sensitivity. JS Vogel KW Turteltaub R Finkel DE Nelson, Anal Chem 1995 67 353A 359A 10.1021/ac00107a001 9306729
4. Elements in biological AMS. JS Vogel J McAninch S Freeman, Nucl Instrume Methods Phys Res B 1997 123 241 249 10.1016/S0168-583X(96)00679-9
5. 14C in human beings. WS Broecker A Schulert EA Olson, Science 1959 130 331 332 10.1126/science.130.3371.331-a 13668562
6. 14C to man. DD Harkness, Nature 1972 240 302 303 10.1038/240302a0 4564595
7. 14C as a biological tracer. MJ Stenhouse MS Baxter, Nature 1977 267 828 832 10.1038/267828a0 895840
8. Accelerator mass spectrometry for quantitative in vivo tracing. JS Vogel, Biotechniques 2005 Suppl 25 29 10.2144/05386SU04 16528913
9. Accelerator mass spectrometry for biomedical research. K Brown KH Dingley KW Turteltaub, Methods Enzymol 2005 402 423 443 10.1016/S0076-6879(05)02014-8 16401518 (Pubitemid 43053135)
10. Big physics, small dosed: the use of AMS and PET in human microdosing of development drugs. G Lappin RC Garner, Nature Rev Drug Discov 2003 2 233 240 10.1038/nrd1037 (Pubitemid 37361669)
11. Use of microdosing to predict pharmacokinetics at the therapeutic dose: experience with 5 drugs. G Lappin W Kuhnz R Jochemsen J Kneer A Chaudhary B Oosterhuis WJ Drijfhout M Rowland RC Garner, Clin Pharmacol Ther 2006 80 203 215 10.1016/j.clpt.2006.05.008 16952487 (Pubitemid 44313903)
12. 14C via accelerator mass spectrometry. TJ Ognibene G Bench JS Vogel GF Peaslee S Murov, Anal Chem 2003 75 2192 2196 10.1021/ac026334j 12720362 (Pubitemid 36542364)
13. Proteomics goes quantitative: measuring protein abundance. H Steen A Pandey, Trends Biotechnol 2002 20 361 364 10.1016/S0167-7799(02)02009-7 12175758 (Pubitemid 34880164)
14. Proteomic tools for quantitation by mass spectrometry. J Lill, Mass Spectrom Rev 2003 22 182 194 10.1002/mas.10048 12838544
15. Attomole quantitation of protein separations with accelerator mass spectrometry. JS Vogel PG Grant BA Buchholz K Dingley KW Turteltaub, Electrophoresis 2001 22 2037 2045 10.1002/1522-2683(200106)22:10<2037::AID- ELPS2037>3.0.CO;2-8 11465504
16. Bioanalytical applications of accelerator mass spectrometry for pharmaceutical research. KW Turteltaub JS Vogel, Curr Pharm Des 2000 6 991 1007 10.2174/1381612003400047 10828298
17. Applications of accelerator mass spectrometry for pharmacological and toxicological research. K Brown EM Tompkins IN White, Mass Spectrom Rev 2006 25 154 159 10.1002/mas.20059
18. Accelerator mass spectrometry in biomedical dosimetry: relationship between low-level exposure and covalent binding of heterocyclic amine carcinogens to DNA. KW Turteltaub JS Felton BL Gledhill JS Vogel JR Southon MW Caffee RC Finkel DE Nelson ID Proctor JC Davis, Proc Natl Acad Sci USA 1990 87 5288 5292 2371271 10.1073/pnas.87.14.5288 (Pubitemid 20260164)
19. Quantitating isotopic molecular labels with accelerator mass spectrometry. JS Vogel AH Love, Methods Enzymol 2005 402 402 422 10.1016/S0076-6879(05)02013-6 16401517 (Pubitemid 43053134)
20. Capillary electrophoresis of catecholamines with laser-induced fluorescence intensified charge-coupled device detection. S Xiong H Han R Zhao Y Chen G Liu, Biomed Chromatogr 2001 15 2 83 88 10.1002/bmc.37 11268047 (Pubitemid 32280105)
21. Analysis of aminofluorescein-fatty acid derivatives by capillary electrophoresis with laser-induced fluorescence detection at the attomole level: application to mycobacterial fatty acids. T Brando C Pardin J Parandi G Puzo, J Chromatogr (A) 2002 973 1- 2 203 210 10.1016/S0021-9673(02)01216-5 12437179 (Pubitemid 35279219)
22. Position paper on non-clinical safety studies to support clinical trials with a single microdose. Committee for Proprietary Medicinal Products, 2003 CPMP/SWP/2599/02
23. Methods of DNA adduct determination and their application to testing compounds for genotoxicity. DH Phillips PB Farmer FA Beland RG Nath MC Poirier MV Reddy KW Turteltaub, Environ Mol Mutagen 2000 35 222 233 10.1002/(SICI)1098- 2280(2000)35:3<222::AID-EM9>3.0.CO;2-E 10737957
24. 14C]2-amino-1-methyl-6- phenulimidazo[4,5-b]pyridine (PhIP). NP Lang S Nowell MA Malfatti KS Kulp MG Knize C Davis JP Massengill S Williams S MacLeod KH Dingley JS Felton KW Turteltaub, Cancer Lett 1999 143 135 138 10.1016/S0304-3835(99)00142-1 10503892 (Pubitemid 29392945)
25. 14C]2-amino-1-methyl-6- phenylimidazole[4,5-b]pyridine metabolites in humans. MA Malfatti KS Kulp MG Knize C Davis JP Massengill S Williams S Nowell S MacLeod KH Dingley KW Turteltaub NP Lang JS Felton, Carcinogenesis 1999 20 705 713 10.1093/carcin/20.4.705 10223203
26. DNA and protein adduct formation in the colon and blood of humans after exposure to a dietary-relevant dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine. KH Dingley KD Curtis S Nowell JS Felton NP Lang KW Turteltaub, Cancer Epidemiology, Biomarkers & Prevention 1999 8 507 512
27. Macromolecular adduct formation and metabolism of heterocyclic amines in humans and rodents at low doses. KW Turteltaub KH Dingley KD Curtis MA Malfatti RJ Turesky RC Garner JS Felton NP Lang, Cancer Lett 1999 143 149 155 10.1016/S0304-3835(99)00116-0 10503895 (Pubitemid 29392948)
28. Identification of urine metabolites of 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine following consumption of a single cooked chicken meal in humans. KS Kulp MG Knize MA Malfatti CP Salmon JS Felton, Carcinogenesis 2000 21 2065 2072 10.1093/carcin/21.11.2065 11062169
29. Factors affecting human heterocyclic amine intake and the metabolism of PhIP. MG Knize KS Kulp CP Salmon GA Keating JS Felton, Mutat Res 2002 506-507 153 162
30. Effect of dietary constituents with chemoprevention potential on adduct formation of a low-dose of the heterocyclic amines PhIP and IQ and phase II hepatic enzymes. KH Dingley EA Ubick ML Chiarappa-Zucca S Nowell S Abel SE Eberler AE Mitchell SA Burns FM Steinberg AJ Clifford, Nutr Cancer 2003 46 212 221 10.1207/S15327914NC4602-15 14690798
31. The effects of coffee on enzymes involved in metabolism of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in rats. RJ Turesky J Richoz A Constable KD Curtis KH Dingley KW Turteltaub, Chem Biol Interact 2003 145 251 265 10.1016/S0009-2797(03)00022-X 12732453 (Pubitemid 36549110)
32. Acrylamide causes preimplantation abnormalities in embryos and induces chromatin-adducts in male germ cells of mice. N Holland T Ahlborn KW Turteltaub C Markee D Moore AJ Wyrobek MT Smith, Reproductive Toxicology 1999 13 167 178 10.1016/S0890-6238(99)00011-8 10378466 (Pubitemid 29264650)
33. Characterization of oxaliplatin-DNA adduct formation in DNA and differentiation of cancer cell drug sensitivity at microdose concentrations. SS Hah RA Sumbad RW de Vere White KW Turteltaub PT Henderson, Chem Res Toxicol 2007 20 1745 1751 10.1021/tx700376a 18001055
34. Kinetics of carboplatin-DNA binding in genomic DNA and bladder cancer cells as determined by accelerator mass spectrometry. SS Hah KM Stivers RW de Vere White PT Henderson, Chem Res Toxicol 2006 19 622 626 10.1021/tx060058c 16696564 (Pubitemid 43800978)
35. Detection of Adriamycin-DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations. KE Coldwell SM Cutts TJ Ognibene PT Henderson DR Phillips, Nucleic Acids Res 2008 36 e100 18632763 10.1093/nar/gkn439
36. Dose-dependent binding of ortho-phenylphenol to protein but not DNA in the urinary bladder of male F344 rats. ES Kwok BA Buchholz JS Vogel KW Turteltaub DA Eastmond, Toxicol Appl Pharmacol 1999 159 18 24 10.1006/taap.1999.8722 10448121 (Pubitemid 29404757)
37. Species and strain comparisons in the macromolecular binding of extremely low dosed of [C-14]benzene in rodents, using accelerator mass spectrometry. C Mani S Freeman DO Nelson JS Vogel KW Turteltaub, Toxicol Appl Pharmacol 1999 159 83 90 10.1006/taap.1999.8707 10495771 (Pubitemid 29426579)
38. Attomole detection of in vivo protein targets of benzene in mice. KE Williams TA Carver JJL Miranda A Kautiainen JS Vogel KH Dingley MA Baldwin KW Turteltaub AL Burlingame, Mol Cell Proteomics 2002 1 885 895 10.1074/mcp.M200067-MCP200 12488464
39. 14C-acetic anhydride and accelerator mass spectrometry. R Goldman BW Day TA Carver RJ Mauthe KW Turteltaub PG Shields, Chem Biol Interact 2000 126 171 183 10.1016/S0009-2797(00)00160-5 10862816 (Pubitemid 30336354)
40. Inhibition of nicotine-DNA adduct formation in mice by six dietary constituents. Y Cheng HL Li HF Wang HF Sun YF Liu SX Peng KX Liu ZY Guo, Food Chem Toxicol 2003 41 1045 1050 10.1016/S0278-6915(03)00032-2 12804663 (Pubitemid 36694513)
41. Benzoate derived DNA adduction and its decay in mice measured by AMS. B Xue HF Wang LH Xu HF Sun YF Liu SX Peng KX Liu ZY Guo, Nucl Instrume Methods Phys Res B 2004 223-224 765 769 10.1016/j.nimb.2004.04.142
42. The formation of AFB1-macromolecular adducts in rats and humans at dietary levels of exposure. BC Cupid TJ Lightfoot D Russell SJ Gant PC Turner KH Dingley KD Curtis SH Leveson KW Turteltaub RC Garner, Food Chem Toxicol 2004 42 559 569 10.1016/j.fct.2003.10.015 15019179 (Pubitemid 38314826)
43. HPLC-Accelerator MS measurements of atrazine metabolites in humans urine after dermal exposure. BA Buchholz E Fultz KW Haack JS Vogel SD Gilman SJ Gee BD Hammock XY Hui RC Wester HI Maibach, Anal Chem 1999 71 3519 3525 10.1021/ac990152g 10464479 (Pubitemid 29387998)
44. Identification of human CYP forms involved in the activation of tamoxifen and irreversible binding to DNA. DJ Boocock K Brown AH Gibbs E Sanchez KW Turteltaub INH White, Carcinogenesis 2002 23 1897 1901 10.1093/carcin/23.11.1897 12419838
45. Tamoxifen DNA damage detected in human endometrium using accelerator mass spectrometry. EA Martin K Brown M Gaskell F Al-Azzawi RC Garner DJ Boocock E Mattock DW Pring KH Dingley KW Turteltaub LL Smith INH White, Cancer Res 2003 63 8461 8465 14679010
46. Motor nerve terminal response to edrophonium in delayed DFP neuropathy. HE Lowndes T Baker WF Riker Jr, Eur J Pharmacol 1975 30 69 72 10.1016/0014-2999(75)90204-6 1122938
47. Clinical evaluation of DFP (diisopropyl fluorophosphate) in glaucoma. O Ferrer, Arch Hosp Univ 1950 2 675 677 14811744
48. Autonomic drugs in ophthalmology: some problems and promises. I. Directly and indirectly acting parasympathomimetic drugs. MG Holland, Ann Ophthalmol 1974 6 447 450 4208894
49. Protein binding of isofluorophate in vivo after coexposure to multiple chemicals. JS Vogel GA Keating II BA Buchholz, Environ Health Perspect 2002 110 1031 1036 12634135
50. Toward a molecular neuropsychiatry of neurodegenerative diseases. JL Cummings, Ann Neurol 2003 54 147 154 10.1002/ana.10616 12891666 (Pubitemid 36909613)
51. In Basic Neurochemistry: Molecular, Cellular and Medical Aspects. DJ Selkoe PT Lansbury, Philadelphia: Lippincott Williams and Wilkins 1999
52. Neuropathological spectrum of synucleinopathies. KA Jellinger, Mov Disord 2003 18 Suppl 6 S2 S12 10.1002/mds.10557 14502650
53. Dementia with Lewy bodies. I McKeith J Mintzer D Aarsland D Burn H Chiu J Cohen-Mansfield D Dickson B Dubois JE Duda H Feldman S Gauthier G Halliday B Lawlor C Lippa OL Lopez J Carlos-Machado J O'Brien J Playfer W Reid, Lancet Neurol 2004 3 19 28 10.1016/S1474-4422(03)00619-7 14693108 (Pubitemid 38018924)
54. Calcium- and activity-dependent synaptic plasticity. RS Zucker, Curr Opin Neurobiol 1999 9 305 313 10.1016/S0959-4388(99)80045-2 10395573 (Pubitemid 29267601)
55. Spike timing, calcium signals and synaptic plasticity. PJ Sjoestroem SB Nelson, Curr Opin Neurobiol 2002 12 305 314 10.1016/S0959-4388(02)00325-2 12049938 (Pubitemid 34618523)
56. Dendrite growth increased by visual activity requires NMDA receptor and Rho GTPases. WC Sin K Haas ES Ruthazer HT Cline, Nature 2002 419 475 480 10.1038/nature00987 12368855
57. Rapid dendritic morphogenesis in CA1 hippocampal dendrites induced by synaptic activity. M Maletic-Savatic R Malinow K Svoboda, Science 1999 283 1923 1927 10.1126/science.283.5409.1923 10082466 (Pubitemid 29144211)
58. Ca(2+) signaling in dendritic spines. BL Sabatini M Maravall K Svoboda, Curr Opin Neurobiol 2001 11 349 356 10.1016/S0959-4388(00)00218-X 11399434 (Pubitemid 32524101)
59. Imaging calcium concentration dynamics in small neuronal comparments. R Yasuda EA Nimchinsky V Scheuss TA Pologruto TG Oertner BL Sabatini K Svoboda, Sci STKE. 2004 2004 219 pI5 10.1126/stke.2192004pl5
60. 41Ca isotope in urine, serum, and saliva samples. Y Lin DJ Hillegonds ER Gertz MD van Loan JS Vogel, Anal Biochem 2004 332 193 195 10.1016/j.ab.2004.05.019 15301966 (Pubitemid 39099488)
61. Evaluation of microdosing strategies for studies in preclinical drug development: Demonstration of linear pharmacokinetics in dogs of a nucleoside analogue over a 50-fold dose range. P Sandhu JS Vogel MJ Rose EA Ubick JE Brunner MA Wallace JK Adelsberger MP Baker PT Henderson PG Pearson TA Baillie, Drug Metab Dispos 2004 32 1254 1259 10.1124/dmd.104.000422 15286054 (Pubitemid 39410909)
62. In vivo relaese from a drug delivery MEMS device. Y Li RS Shawgo B Tyler PT Henderson JS Vogel A Rosenberg PB Storm R Langer H Brem MJ Cima, J Controlled Release 2004 100 211 219 10.1016/j.jconrel.2004.08.018 (Pubitemid 39491273)
63. New technologies for nutrition research. SA Ross PR Srinivas AJ Clifford SC Lee MA Philbert RL Hettich, J Nutr 2004 134 681 685 14988467
64. Semiparametric modeling of labeled-cell kinetics, with application to isotope labeling of erythrocytes. HG Muller CL Su SR Duecker Y Lin BA Buchholz JS Vogel, Biometrics 2002 58 937 945 10.1111/j.0006-341X.2002.00937.x 12495148
65. Shrinkage estimation for functional principal component scores with application to the population kinetics of plasma folate. F Yao HG Mueller AJ Clifford SR Dueker JR Follett Y Lin BA Buchholz JS Vogel, Biometrics 2003 59 676 685 10.1111/1541-0420.00078 14601769 (Pubitemid 37093407)
66. Use of an oral/intravenous dual-label stable-isotope protocol to determine folic acid bioavailability from fortified cereal grain foods in women. PM Finglas CM Witthoft L Vahteristo AJ Wright S Southon FA Mellon B Ridge P Maunder, J Nutr 2002 132 936 939 11983817
67. Kinetics of folate turnover in pregnant women (second trimester) and nonpregnant controls during folic acid supplementation: stable-isotopic labeling of plasma folate, urinary folate and folate catabolites shows subtle effects of pregnancy on turnover of folate pools. JF Gregory III MA Caudill FJ Opalko LB Bailey, J Nutr 2001 131 1928 1937 11435509
68. Quantitation of in vivo human folate metabolism. Y Lin SR Dueker JR Follett JG Fadel A Arjomand PD Schneider JW Miller R Green BA Buchholz JS Vogel RD Phair AJ Clifford, Am J Clin Nutr 2004 80 680 691 15321809
69. Neural tube defects along the Texas-Mexico border, 1993-1995. KA Hendricks JS Simpson RD Larsen, Am J Epidemiol 1999 149 1119 1127 10369506
70. The epidemiology of viral hepatitis in children in South Texas: increases prevalence of hepatitis A along the Texas-Mexico border. CT Leach FC Koo SG Hilsenbeck HB Jenson, J Infect Dis 1999 180 509 513 10.1086/314861 10395871 (Pubitemid 30256337)
71. Neural tube defects among Mexican Americans living on the US-Mexico border: effects of folic acid and dietary folate. L Suarez KA Hendricks SP Cooper AM Sweeney RJ Hardy RD Larsen, Am J Epidemiol 2000 152 1017 1023 10.1093/aje/152.11.1017 11117610
72. Investigation of folate pathway gene polymorphisms and the incidence of neural tube defects in a Texas hispanic population. R Barber S Shalat KA Hendricks B Joggerst RD Larsen L Suarez R Finnell, Mol Genet Metab 2000 70 45 52 10.1006/mgme.2000.2991 10833330 (Pubitemid 30396203)
73. Hyperhomocysteinemia in liver cirrhosis: mechanisms and role in vascular and hepatic fibrosis. ER Garcia-Tevijano C Berasain JA Rodriguez FJ Corrales R Arias A Martin-Duce J Caballeria JM Mato MA Avila, Hypertension 2001 38 1217 1221 10.1161/hy1101.099499 11711526
74. 3-methyl-1-C]methionine. S Russmann E Junker BH Lauterburg, Hepatology 2002 36 1190 1196 10.1053/jhep.2002.36499 12395329 (Pubitemid 35253435)
75. Long-term kinetic study of beta-carotene, using accelerator mass spectrometry in an adult volunteer. SR Duecker Y Lin BA Buchholz PD Schneider MW Lame HJ Segall JS Vogel AJ Clifford, J Lipid Res 2000 41 1790 1800 11060348
76. Dual isotope test for assessing beta-carotene cleavage to vitamin A in humans. SJ Hickenbottom SL Lemke SR Duecker Y Lin JR Follett C Carkeet BA Buchholz JS Vogel, Eur J Nutr 2002 41 141 147 10.1007/s00394-002-0368-0 12242581 (Pubitemid 36056322)
77. Absorption and retinol equivalence of beta-carotene in humans is influenced by dietary vitamin A intake. SL Lemke SR Duecker JR Follett Y Lin C Carkeet BA Buchholz JS Vogel AJ Clifford, J Lipid Res 2003 44 1591 1600 10.1194/jlr.M300116-JLR200 12777466 (Pubitemid 37279605)
78. Mass spectrometric immunoassay for parathyroid hormone-related protein. CM Lu DW Burton RL Fitzgerald LJ Deftos BA Buchholz JS Vogel DA Herold, Anal Chem 2002 74 5507 5512 10.1021/ac020182a 12433080 (Pubitemid 35253112)
79. Isotope-labeled immunoassays without radiation waste. G Shan W Huang SJ Gee BA Buchholz JS Vogel BD Hammock, Proc Natl Acad Sci USA 2000 97 2445 2449 10706612 10.1073/pnas.040575997 (Pubitemid 30159190)
80. Attomole level protein sequencing by Edman degradation coupled with accelerator mass spectrometry. M Miyashita JM Presley BA Buchholz KS Lam YM Lee JS Vogel BD Hammock, Proc Natl Acad Sci USA 2001 98 4403 4408 11287636 10.1073/pnas.071047998 (Pubitemid 32294989)
81. Incorporation of extracellular 8-oxodG into DNA and RNA requires purine nucleoside phosphorylase in MCF-7 cells. JM Mundt SS Hah RA Sumbad V Schramm PT Henderson, Nucleic Acids Res 2008 36 228 236 18025045 10.1093/nar/gkm1032
82. Measurement of 7,8-dihydro-8-oxo-2'-deoxyguanosine metabolism in MCF-7 cells at low concentrations using accelerator mass spectrometry. SS Hah JM Mundt HM Kim RA Sumbad KW Turteltaub PT Henderson, Proc Natl Acad Sci USA 2007 104 11203 11208 17592118 10.1073/pnas.0701733104 (Pubitemid 47175119)
83. A sample preparation protocol for quantification of radiolabeled nucleoside incorporation into DNA by accelerator mass spectrometry. SS Hah JM Mundt EA Ubick KW Turteltaub JP Gregg PT Henderson, Nucl Instr Methods Phys Res B 2007 259 763 766 10.1016/j.nimb.2007.01.214 (Pubitemid 46726825)
84. Targeting a novel Plasmodium falciparum purine recycling pathway with specific immucillins. LM Ting W Shi A Lewandowicz V Singh A Mwakingwe MR Birck EAT Ringia G Bench DC Madrid PC Tyler GB Evans RH Furneaux VL Schramm K Kim, J Biol Chem 2005 280 9547 9554 10.1074/jbc.M412693200 15576366 (Pubitemid 40409650)
85. Retrospective birth dating of cells in humans. KL Spalding RD Bhardwaj BA Buchholz H Druid J Frisen, Cell 2005 122 133 143 10.1016/j.cell.2005.04.028 16009139 (Pubitemid 40977946)
86. 14C data. M Stuiver HA Polach, Radiocarbon 1977 19 355 363
87. INTCAL98 radiocarbon age calibration, 24000-0 cal BP. M Stuiver PJ Reimer E Bard JW Beck GS Burr KA Hughen B Kromer G McCormac J van der Plicht M Spurk, Radiocarbon 1998 40 1041 1083
88. 14CO 2 level in midlatitudes of the northern hemisphere (1959-2003). I Levin B Kromer, Radiocarbon 2004 46 1261 1272
89. Forensics: age written in teeth by nuclear tests. KL Spalding BA Buchholz LE Bergman H Druid J Frisen, Nature 2005 437 333 334 10.1038/437333a 16163340 (Pubitemid 41613486)
90. Dynamics of fat cell turnover in humans. KL Spalding E Arner PO Westermark S Bernard BA Buchholz O Bergmann L Blomqvist J Hoffstedt E Naslund T Britton H Concha M Hassan M Ryden J Frisen P Arner, Nature 2008 453 783 787 10.1038/nature06902 18454136 (Pubitemid 351793777)
91. Use of bomb pulse C-14 to age senile plaques and neurofibrillary tangles in the Alzheimer's disease brain. JD Robertson MA Lovell BA Buchholz CS Xie WR Markesbery, J Radioanal Nucl Chem 2001 249 443 447 10.1023/A:1013299426601 (Pubitemid 32772322)
92. Use of bomb pulse carbon-14 to age senile plaques and neurofibrillary tangles in Alzheimer's disease. MA Lovell JD Robertson BA Buchholz CS Xie WR Markesbery, Neurobiol Aging 2002 23 179 186 10.1016/S0197-4580(01)00281-0 11804701 (Pubitemid 34137091)